Mankind Pharma

Mankind Pharma
Public
Industry Pharmaceutical
Founded 1995 (1995)
Founder R C Juneja
Headquarters Okhla, Delhi, India
Key people
Rajeev Juneja, Arjun Juneja, Sheetal Arora, P.K. Arora, Ajay Bansal
Products Pharmaceuticals, Generic drugs, OTC, FMCG, Diagnostics
Revenue US$ 800 million (2017-18)
Number of employees
10000+
Subsidiaries Discovery, Lifestar, Lifestar 2, Special, Vet, Future, Magnet
Website www.mankindpharma.com

Mankind Pharma is a pharmaceutical company in India based at New Delhi. The company has products in therapeutic areas ranging from antibiotics, to gastrointestinal, cardiovascular, dermal, and erectile dysfunction medications.

The company was formed in 1991. It started working as a fully integrated pharmaceutical company in 1995 with the contributions of two brothers, R C Juneja and Rajeev Juneja. The seed capital for establishing the company was 50 Lakh.[1] The company was started with 20 employees and launched in two states in the 1st year of its operation.[2]

The company acquired Magnet Labs Pvt. Ltd. to enter the antipsychotic segment in 2007.[3] Also it acquired Longifene-an appetite stimulant for children, in January 2010 which was earlier a brand of UCB Belgium.[4]

References

  1. Hussain, Shabana (8 May 2014). "Mankind Pharma: Formulating Strategy To Enter The Big League". Retrieved 27 June 2018.
  2. "A Giant Leap For Mankind". Business Outlook India. 24 December 2011. Archived from the original on 29 June 2012. Retrieved 5 February 2013.
  3. Acquisition of Magnet Labs
  4. Mankind Pharma markets Longifene- 29 August 2011
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.